DAYPRO ALTA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Daypro Alta, and what generic alternatives are available?
Daypro Alta is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DAYPRO ALTA is oxaprozin potassium. There are thirteen drug master file entries for this compound. Additional details are available on the oxaprozin potassium profile page.
Summary for DAYPRO ALTA
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 8 |
Clinical Trials: | 1 |
Patent Applications: | 122 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DAYPRO ALTA at DailyMed |
Recent Clinical Trials for DAYPRO ALTA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Sanford Research | Early Phase 1 |
Anatomical Therapeutic Chemical (ATC) Classes for DAYPRO ALTA
US Patents and Regulatory Information for DAYPRO ALTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DAYPRO ALTA | oxaprozin potassium | TABLET;ORAL | 020776-001 | Oct 17, 2002 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DAYPRO ALTA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | DAYPRO ALTA | oxaprozin potassium | TABLET;ORAL | 020776-001 | Oct 17, 2002 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DAYPRO ALTA
See the table below for patents covering DAYPRO ALTA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 299699 | ⤷ Try a Trial | |
European Patent Office | 0901372 | FORMULATIONS PHARMACEUTIQUES CONTENANT DU POTASSIUM, DU SODIUM ET DES SELS TRIS D'OXAPROZINE (POTASSIUM, SODIUM AND TRIS OXAPROZIN SALT PHARMACEUTICAL FORMULATIONS) | ⤷ Try a Trial |
Norway | 985414 | ⤷ Try a Trial | |
Spain | 2248850 | ⤷ Try a Trial | |
Israel | 126998 | POTASSIUM, SODIUM OR TRIS OXAPROZIN SALT PHARMACEUTICAL FORMULATIONS | ⤷ Try a Trial |
Taiwan | 586929 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |